Fig. 11From: Disulfidptosis-related signatures for prognostic and immunotherapy reactivity evaluation in hepatocellular carcinomaPrediction of response to chemotherapeutic drug reactivity. A-C IC50 bar plots of gemcitabine (A), vinorelbine (B) and paclitaxel (C) among different high-risk and low-risk subgroups. D–F IC50-related ROC curves of gemcitabine (D), vinorelbine (E), and paclitaxel (F). (****p < 0.0001)Back to article page